In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Associate Professor Kiril Karamfiloff

University Hospital Alexandrovska, Sofia (Bulgaria)

Speciality : Interventional Cardiology

8 presentations from this speaker

Predictors of survival after bifurcation stenting (practical insights from COSIBRIA registry)

Congress : ESC Congress 2019

  • Session : High risk percutaneous coronary intervention: STEMI, CTO, atherectomy bifurcations shock
  • Speaker : K Karamfiloff (Sofia,BG)

Bleeding complication while on DAPT after PCI.

Congress : ESC Congress 2018

  • Session : Guidelines in Daily Practice - DAPT
  • Speaker : K Karamfiloff (Sofia,BG)
  • Organised with the Bulgarian Society of Cardiology

FFR guided treatment of bifurcation stenosis

Congress : ESC Congress 2017

  • Session : Coronary artery disease: from bench to bedside
  • Speaker : K Karamfiloff (Sofia,BG)

Main vessel score - a simple tool to predict functional significant main vessel stenosis requiring treatment in coronary bifurcation lesions

Congress : ESC Congress 2017

  • Session : Coronary morphology and functional assessment (4)
  • Speaker : K Karamfiloff (Sofia,BG)

Mortality prediction at five years after PCI of bifurcaton stenoses - intracoronary ECG mortality score (IEMS)

Congress : ESC Congress 2017

  • Session : Determinants of long-term post-PCI outcomes
  • Speaker : K Karamfiloff (Sofia,BG)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are